Royal Bank of Canada
HAE icon

Royal Bank of Canada’s Haemonetics HAE Stock Holding History

Royal Bank of Canada’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,000
Closed -$312K – 6983
2024
Q4 		$312K Sell
4,000
-5,000
-56% -$402K ﹤0.01% 4447
2024
Q3 		$723K Buy
+9,000
New +$727K ﹤0.01% 3802
2024
Q1 		– Sell
-8,500
Closed -$727K – 7234
2023
Q4 		$727K Buy
+8,500
New +$735K ﹤0.01% 3935

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada's HAE Position: Q1 2026 in Review

Royal Bank of Canada reduced its Haemonetics (HAE) stake by 11% in Q1 2026, selling an estimated $7.14M and leaving 857,965 shares worth $48.4M. The position accounts for 0.01% of the portfolio, ranked #930.

Royal Bank of Canada first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $81.9M in Q4 2024. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Royal Bank of Canada held 857,965 shares of Haemonetics worth $48.4M as of Q1 2026.
  • Royal Bank of Canada sold 109,628 Haemonetics shares in Q1 2026, an estimated $7.14M.
  • Haemonetics made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #930 holding.
  • Royal Bank of Canada first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Haemonetics position peaked at $81.9M in Q4 2024.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.